Kai‐Chia Yeh

Design and Synthesis of Tetrahydropyridothieno[2,3-<i>d</i>]pyrimidine Scaffold Based Epidermal Growth Factor Receptor (EGFR) Kinase Inhibitors: The Role of Side Chain Chirality and Michael Acceptor Group for Maximal Potency

Chia-Hsien Wu, Mohane Selvaraj Coumar, Chang-Ying Chu et al. · Journal of Medicinal Chemistry · 2010 · 109 citations · Full text

Kinase Inhibitors, Molecular Biology, Side Chain Chirality +20

A highly selective and potent CXCR4 antagonist for hepatocellular carcinoma treatment

Jen‐Shin Song, Chih-Chun Chang, Chien-Huang Wu et al. · Proceedings of the National Academy of Sciences · 2021 · 86 citations · Full text

Interim safety analysis from TYTAN: A phase III Asian study of lapatinib in combination with paclitaxel as second-line therapy in gastric cancer.

Taroh Satoh, Yung‐Jue Bang, J. Wang et al. · Journal of Clinical Oncology · 2010 · 35 citations

Gastrointestinal Oncology, Medicine, Cancer Management +12

A Novel CXCR4 Antagonist CX549 Induces Neuroprotection in Stroke Brain

Kuo‐Jen Wu, Seong‐Jin Yu, Kak‐Shan Shia et al. · Cell Transplantation · 2017 · 35 citations · Full text

Immunology, Stroke Brain, Immunotherapy +22

Discovery of a Furanopyrimidine-Based Epidermal Growth Factor Receptor Inhibitor (DBPR112) as a Clinical Candidate for the Treatment of Non-Small Cell Lung Cancer

Shu‐Yu Lin, Yung Chang Hsu, Yi-Hui Peng et al. · Journal of Medicinal Chemistry · 2019 · 35 citations · Full text